Elevation Wealth Partners’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1K Buy
1,203
+431
+56% +$6.68K 0.01% 607
2026
Q1
$10.4K Buy
772
+26
+3% +$364 ﹤0.01% 504
2025
Q4
$9.29K Buy
746
+671
+895% +$7.24K ﹤0.01% 496
2025
Q3
$743 Buy
+75
New +$730 ﹤0.01% 775
2024
Q1
Sell
-714
Closed -$7.04K 508
2023
Q4
$7.04K Hold
714
﹤0.01% 352
2023
Q3
$7.04K Buy
714
+6
+0.8% +$62 0.01% 259
2023
Q2
$7.07K Buy
708
+5
+0.7% +$48 0.01% 265
2023
Q1
$6.76K Buy
+703
New +$7.8K 0.01% 277

Other funds holding VTRS

Elevation Wealth Partners's VTRS Position: Q2 2026 in Review

Elevation Wealth Partners increased its Viatris (VTRS) stake by 56% in Q2 2026, buying an estimated $6.68K and bringing the position to 1,203 shares worth $19.1K. The position accounts for 0.01% of the portfolio, ranked #607.

Elevation Wealth Partners first reported a position in VTRS in Q1 2023 and has held it in 8 quarters since. 386 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Elevation Wealth Partners held 1,203 shares of Viatris worth $19.1K as of Q2 2026.
  • Elevation Wealth Partners bought 431 Viatris shares in Q2 2026, an estimated $6.68K.
  • Viatris made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #607 holding.
  • Elevation Wealth Partners first reported a position in Viatris in Q1 2023 and has held it in 8 quarters since.
  • 386 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.